Navigation Links
IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
Date:10/28/2008

MOUNTAIN VIEW, Calif., Oct. 28 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its third quarter 2008 financial results after the market closes on Tuesday, November 4, 2008. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, November 4, 2008 to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by dialing (866) 250-4375 (US) or (303) 262-2161 (International), or by visiting the Company's website at http://www.iridex.com. A telephone replay will be available beginning on Tuesday, November 4, 2008 through Tuesday, November 11, 2008 by dialing (800) 405-2236 (US) or (303) 590-3000 (International) and entering Passcode 11122023#.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. IRIDEX Reports First Quarter 2008 Financial Results
2. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
3. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
4. IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
5. IRIDEX Reports Third Quarter Financial Results
6. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
7. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
8. James B. Hawkins Appointed to IRIDEX Board of Directors
9. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
10. William Moore Appointed to IRIDEX Board of Directors
11. IRIDEX Announces Closing of $5.0 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... , ... Mercy College is expanding its Graduate Business Programs to the Bronx ... to high demand: Master of Business Administration (MBA), Master of Organizational Leadership (MSOL) and ... School of Business Graduate Program Chair Dr. Ray Manganelli said: “We believe that people ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Council for Graduate Medical Education (ACGME) that it has received accreditation for its ... accreditation of three residency programs that Memorial is currently pursuing, including Pediatrics and ...
(Date:4/29/2016)... Atlanta, Georgia (PRWEB) , ... April 29, 2016 , ... ... 60 rural hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on ... by Rep. Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced efforts ... more information about their loan terms and accounts, and more protections for borrowers. ... federal and private loans, has reached $1.3 trillion, with 43 million Americans holding ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... infants born with severe congenital diaphragmatic hernia have better survival rates if surgery ... diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 ReportsnReports.com ... 2016" market research report that provides an overview ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... will notably complement the company,s valve repair and ... the move also places Abbott more firmly into ... one of the fastest growing device areas, with ... to its recent report,  Advanced Remote Patient ...
Breaking Medicine Technology: